Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DECIBEL THERAPEUTICS, INC.

(DBTX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/10/2022 01/11/2022 01/12/2022 01/13/2022 01/14/2022 Date
4.53(c) 4.61(c) 4.82(c) 4.66(c) 4.66(c) Last
92 628 38 999 93 255 61 858 59 173 Volume
+2.95% +1.77% +4.56% -3.32% 0.00% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 1,06 M - -
Net income 2021 -52,9 M - -
Net Debt 2021 - - -
P/E ratio 2021 -2,19x
Yield 2021 -
Sales 2022 26,6 M - -
Net income 2022 -61,9 M - -
Net Debt 2022 - - -
P/E ratio 2022 -2,28x
Yield 2022 -
Capitalization 116 M 116 M -
Capi. / Sales 2021 109x
Capi. / Sales 2022 4,37x
Nbr of Employees 40
Free-Float -
More Financials
Company
Decibel Therapeutics Inc is a clinical-stage biotechnology company. The Company is focused on discovering and developing transformative treatments for hearing and balance disorders. The Company is focused on restoring and improving hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support cells within the inner ear. The Company has built a platform that integrates... 
More about the company
Ratings of Decibel Therapeutics, Inc.
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
-
More Ratings
All news about DECIBEL THERAPEUTICS, INC.
01/04Decibel Therapeutics to Present at the H.C. Wainwright BioConnect Conference
AQ
2021DECIBEL THERAPEUTICS, INC.(NASDAQGS : DBTX) added to NASDAQ Biotechnology Index
CI
2021DECIBEL THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021Decibel Therapeutics Announces Appointments of Alison Finger, MBA and Saraswathy Nochur..
AQ
2021Decibel Therapeutics, Inc. Announces Board Changes
CI
2021Decibel Therapeutics Announces Appointments of Alison Finger, MBA and Saraswathy Nochur..
GL
2021JonesTrading Starts Decibel Therapeutics at Buy with $25 Price Target
MT
2021Regeneron Extends Research Collaboration With Decibel Therapeutics; Decibel Shares Rise..
MT
2021Decibel Therapeutics Announces Extension of Research Term under Strategic Collaboration..
AQ
2021HC Wainwright Starts Decibel Therapeutics at Buy With $23 Price Target
MT
2021Citigroup Adjusts Price Target on Decibel Therapeutics to $20 From $29, Reiterates Buy ..
MT
2021Decibel Therapeutics Reports Third Quarter 2021 Financial Results and Corporate Update
AQ
2021DECIBEL THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition..
AQ
2021Decibel Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2021Decibel Therapeutics to Present at the Barclays Gene Editing & Gene Therapy Summit
AQ
More news
News in other languages on DECIBEL THERAPEUTICS, INC.
2021Regeneron prolonge sa collaboration de recherche avec Decibel Therapeutics ; les action..
2021Le principal agent comptable de Decibel Therapeutics, Ronald Vigliotta, prévoit de démi..
2021Decibel Therapeutics nomme un nouveau président du conseil d'administration
More news
Analyst Recommendations on DECIBEL THERAPEUTICS, INC.
More recommendations
Chart DECIBEL THERAPEUTICS, INC.
Duration : Period :
Decibel Therapeutics, Inc. Technical Analysis Chart | DBTX | US24343R1068 | MarketScreener
Technical analysis trends DECIBEL THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 4,66 $
Average target price 21,60 $
Spread / Average Target 364%
EPS Revisions
Managers and Directors
Laurence E. Reid President, Chief Executive Officer & Director
Elisabeth Leiderman Chief Financial & Accounting Officer
William H. Carson Chairman
John J. Lee Chief Scientific Officer
Heather Wolff Vice President-Clinical Development Operations
Sector and Competitors
1st jan.Capi. (M$)
DECIBEL THERAPEUTICS, INC.0.22%116
MODERNA, INC.-19.39%83 008
LONZA GROUP AG-15.15%52 584
IQVIA HOLDINGS INC.-12.33%47 252
SEAGEN INC.-11.33%25 068
ICON PUBLIC LIMITED COMPANY-13.98%21 684